Updated Jul 16, 2026 · Last SEC filing 2026-07-06
Kiniksa Pharmaceuticals International, plc (KNSA) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-06. 4 Form 8-K material event filings were reported by KNSA in the last 90 days. 2 Form 144 notices of proposed sale were filed for KNSA stock. InsiderAlpha tracks every KNSA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001730430 |
| Form 4 filings (90d) | 13 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-06 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Patel Sanj K | CHAIRMAN & CEO | J — Other acquisition / disposition | 900.0K | — | — | SEC | |
| Cole G Bradley | Insider | M — Option exercise | 2.8K | — | — | SEC | |
| BAKER BROS. ADVISORS LP | Insider | A — Grant or award | 6.1K | $0.00 | — | SEC | |
| BAKER BROS. ADVISORS LP | Insider | A — Grant or award | 6.1K | $0.00 | — | SEC | |
| Malley Thomas | Insider | M — Option exercise | 2.8K | — | — | SEC | |
| McCain Tracey L | Insider | M — Option exercise | 2.8K | — | — | SEC | |
| Quart Barry D | Insider | M — Option exercise | 2.8K | — | — | SEC | |
| Levy Richard S | Insider | M — Option exercise | 2.8K | — | — | SEC | |
| Popovits Kimberly J | Insider | M — Option exercise | 2.8K | — | — | SEC | |
| Patel Sanj K | CHAIRMAN & CEO | S — Open-market sale | 48.6K | $54.02 | $2.62M | SEC | |
| Patel Sanj K | CHAIRMAN & CEO | M — Option exercise | 48.6K | $30.93 | $1.50M | SEC | |
| Paolini John F. | CHIEF MEDICAL OFFICER | S — Open-market sale | 21.1K | $54.04 | $1.14M | SEC | |
| Paolini John F. | CHIEF MEDICAL OFFICER | M — Option exercise | 58.4K | $10.36 | $605K | SEC | |
| Paolini John F. | CHIEF MEDICAL OFFICER | S — Open-market sale | 37.3K | $53.52 | $2.00M | SEC | |
| Patel Sanj K | CHAIRMAN & CEO | S — Open-market sale | 2.1K | $54.01 | $116K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Kiniksa Pharmaceuticals International, plc (KNSA). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Patel Sanj K | 19 | $37.38M |
| Quart Barry D | 7 | $844K |
| Malkani Dhiraj H | 6 | — |
| Levy Richard S | 4 | — |
| BAKER BROS. ADVISORS LP | 4 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in KNSA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live KNSA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.